Abbott Laboratories
ABT
C$180.67
Share price
0.21%
Change (1 day)
28.31%
Change (1 year)
Categories
Abbott Laboratories (ABT), (founding name: Abbott Alkaloid Company) is a global pharmaceutical company with around 73,000 employees in 150 countries. Abbott was founded in 1888 by Wallace C. Abbott (1857-1921) and is headquartered in Abbott Park, a northern suburb of Chicago, Illinois.
Market capitalization of Abbott Laboratories (ABT)
Market cap: C$314.34 Billion
As of July 2025 Abbott Laboratories has a market cap of C$314.34 Billion. This makes Abbott Laboratories the world's 58th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Abbott Laboratories from 1996 to 2025
End of year Market Cap
| Year | Marketcap | Change |
|---|---|---|
| 2025 | C$314.34 B | 9.83% |
| 2024 | C$286.20 B | 12.92% |
| 2023 | C$253.44 B | -2.43% |
| 2022 | C$259.75 B | -18.1% |
| 2021 | C$317.16 B | 28.18% |
| 2020 | C$247.43 B | 23.75% |
| 2019 | C$199.94 B | 15.59% |
| 2018 | C$172.97 B | 38.5% |
| 2017 | C$124.89 B | 64.34% |
| 2016 | C$75.99 B | -17.17% |
| 2015 | C$91.74 B | 16.45% |
| 2014 | C$78.78 B | 24.73% |
| 2013 | C$63.16 B | -38.49% |
| 2012 | C$102.69 B | 15.25% |
| 2011 | C$89.10 B | 20.27% |
| 2010 | C$74.08 B | -15.92% |
| 2009 | C$88.11 B | -12.48% |
| 2008 | C$100.68 B | 15.97% |
| 2007 | C$86.81 B | -0.42% |
| 2006 | C$87.18 B | 23.38% |
| 2005 | C$70.66 B | -19.16% |
| 2004 | C$87.41 B | -8% |
| 2003 | C$95.01 B | -4.23% |
| 2002 | C$99.21 B | -28.47% |
| 2001 | C$138.70 B | 23.64% |
| 2000 | C$112.18 B | 38.46% |
| 1999 | C$81.02 B | -29.06% |
| 1998 | C$114.21 B | 59.72% |
| 1997 | C$71.50 B | 31.21% |
| 1996 | C$54.50 B |
End of Day market cap according to different sources
On Jul 14th, 2025 the market cap of Abbott Laboratories was reported to be:
C$315.08 Billion
C$315.10 Billion
Market capitalization for similar companies or competitors
| Name | Marketcap | Market cap differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | C$512.93 B | 63.18% | 🇺🇸 USA |
 Pfizer PFE | C$191.65 B | -39.03% | 🇺🇸 USA |
 Thermo Fisher Scientific TMO | C$216.71 B | -31.06% | 🇺🇸 USA |
 Hologic HOLX | C$19.48 B | -93.80% | 🇺🇸 USA |
 Medtronic MDT | C$156.59 B | -50.18% | 🇮🇪 Ireland |
 Bristol-Myers Squibb BMY | C$129.51 B | -58.80% | 🇺🇸 USA |
 Boston Scientific BSX | C$210.35 B | -33.08% | 🇺🇸 USA |
 AstraZeneca AZN | C$299.58 B | -4.69% | 🇬🇧 UK |
 Novartis NVS | C$324.52 B | 3.24% | 🇨🇭 Switzerland |
 GlaxoSmithKline GSK | C$104.61 B | -66.72% | 🇬🇧 UK |